Live Breaking News & Updates on Sunshine Biopharma

Stay updated with breaking news from Sunshine biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips SBFM stock results show that Sunshine Biopharma missed analyst estimates for earnings per share… ....

Market News , Stock Advice , Sunshine Biopharma , Sunshine Biopharma Misses , Beats Revenue , Reaking News ,

Sunshine Biopharma, Inc.: Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Sunshine Biopharma, Inc.: Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Camille Sebaaly , Nora Pharma , Dennis Riedl , Steve Slilaty , Securities Exchange , Company Income Statement , Sunshine Biopharma Inc , Sales Grew , Average Rate , Per Quarter During , Sunshine Biopharma , Thursday March , Income Statement , Securities Act , Securities Exchange Act , Additional Information Contact ,

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Sales Grew at an Average Rate of 14% Per Quarter During the YearNEW YORK, NY / ACCESSWIRE / April 1, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals toda. ....

United States , Camille Sebaaly , Steve Slilaty , Nora Pharma , Sunshine Biopharma Inc , Company Income Statement , Securities Exchange , Sales Grew , Average Rate , Per Quarter During , Sunshine Biopharma , Thursday March , Income Statement , Securities Act , Securities Exchange Act , Additional Information Contact ,